4.6 Article

Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma

Yataro Daigo et al.

GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2008)

Review Pharmacology & Pharmacy

Chemotherapy for advanced gastric cancer: across the years for a standard of care

Mario Scartozzi et al.

EXPERT OPINION ON PHARMACOTHERAPY (2007)

Article Oncology

Global cancer statistics, 2002

DM Parkin et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2005)

Article Biochemistry & Molecular Biology

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)

S Kakiuchi et al.

HUMAN MOLECULAR GENETICS (2004)

Review Oncology

Palliative chemotherapy for advanced gastric cancer

SS Wöhrer et al.

ANNALS OF ONCOLOGY (2004)